APA (7th ed.) Citation

Marchesi, F., Salmanton-García, J., Buquicchio, C., Itri, F., Besson, C., Dávila-Valls, J., . . . García-Bordallo, D. (2023). Passive pre-exposure immunization by tixagevimab/cilgavimab in patients with hematological malignancy and COVID-19: Matched-paired analysis in the EPICOVIDEHA registry. Journal of Hematology & Oncology, 16(1), 1. https://doi.org/10.1186/s13045-023-01423-7

Chicago Style (17th ed.) Citation

Marchesi, Francesco, et al. "Passive Pre-exposure Immunization by Tixagevimab/cilgavimab in Patients with Hematological Malignancy and COVID-19: Matched-paired Analysis in the EPICOVIDEHA Registry." Journal of Hematology & Oncology 16, no. 1 (2023): 1. https://doi.org/10.1186/s13045-023-01423-7.

MLA (9th ed.) Citation

Marchesi, Francesco, et al. "Passive Pre-exposure Immunization by Tixagevimab/cilgavimab in Patients with Hematological Malignancy and COVID-19: Matched-paired Analysis in the EPICOVIDEHA Registry." Journal of Hematology & Oncology, vol. 16, no. 1, 2023, p. 1, https://doi.org/10.1186/s13045-023-01423-7.